Navigation Links
TYRX AIGISRx antibacterial envelope shows low infection rate, high CIED procedure success
Date:10/19/2010

Monmouth Junction, NJ (October 19, 2010) Patients undergoing CIED (Cardiac Implantable Electronic Device) implantation with TYRX, Inc.'s FDA-cleared AIGISRx Antibacterial Envelope enjoyed a 99.5% rate of successful implantation with an overall infection rate of 0.48% in the first 1.9 months following the procedure, as reported in newly published results of TYRX's COMMAND Clinical Study. There were no infections in patients receiving initial implantations of pacemakers, implantable cardioverter-defibrillators, or cardiac resynchronization therapy devices. The infection rate within the highest risk cohort, ICD/CRT-D replacements/revisions, demonstrated 70% fewer infections than some previous studies.

Results of the COMMAND Study included data from 642 consecutive CIED implantation or revision/replacement procedures utilizing the AIGISRx Antibacterial Envelope at 10 U.S. medical centers. The results were published in the October on-line issue of Pacing and Clinical Electrophysiology, the official journal of the International Cardiac Pacing and Electrophysiology Society.

"The COMMAND Study provides additional evidence that the AIGISRx Antibacterial Envelope offers physicians an effective means for addressing the significant unmet clinical need for additional CIED infection prophylaxis as described in the American Heart Association and Heart Rhythm Society CRM Infection Guidelines published earlier this year," stated Heather Bloom, MD, Director of Electrophysiology at the Atlanta VA Medical Center, Assistant Professor of Medicine, Emory University, and lead author on the COMMAND Study report.

The COMMAND Study, the first clinical study of patients undergoing CIED implantation with the AIGISRx Antibacterial Envelope, was a retrospective cohort study in patients receiving implantation of a pacemaker, implanted cardioverter-defibrillator (ICD), or cardiac resynchronization therapy (CRT) device. The primary endpoints of the study w
'/>"/>

Contact: Joan Kureczka
Joan@kureczka-martin.com
Kureczka/Martin Associates
Source:Eurekalert

Page: 1 2

Related biology news :

1. Antibacterial peptide could aid in treating soldiers burn wound infections
2. Antibacterial silver nanoparticles are a blast
3. Mineral studies advance antibacterial alternatives
4. RD114 envelope proteins provide an effective and versatile approach to pseudotype lentiviral vectors
5. Shifting forms: Penn study shows how variations of same protein affect immune response
6. Faster CARS, less damage: NIST chemical microscopy shows potential for cell diagnostics
7. Meta-analysis shows no heart benefits for folic acid supplements
8. Investigational ovarian cancer drug shows promise against platinum resistant disease
9. New study shows benefits of Bt corn to farmers
10. T cell discovery shows promise for Type 1 diabetes treatment: UBC-CFRI study
11. 1st census shows life in planet ocean is richer, more connected, more altered than expected
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... 21, 2015 High crime ... are boosting access control systems market in ... a recently published report by TechSci Research " Saudi ... access control systems market in Saudi Arabia ... 2020.The access control systems market in the Kingdom is ...
(Date:4/14/2015)... , April 14, 2015  HYPR Corp. today ... (FIDO ® ) Alliance tm , an industry ... members commit to share technology and collaborate to ... are interoperable, more secure and private, and easier ... identity verification that protects sensitive user information and ...
(Date:4/10/2015)... 10, 2015 Research and Markets ... "Security Competitive Profiles - NEC" report to ... NEC will continue to supply a range of ... with a company focus on the development of a ... Winning opportunities in the Asia-Pacific ...
Breaking Biology News(10 mins):Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 2Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 3HYPR Corp. Joins the FIDO Alliance 2HYPR Corp. Joins the FIDO Alliance 3NEC Security Competitive Profile 2015 2
... WV Blue mold, caused by the fungus Penicillium ... throughout the world, causing extensive losses to stored apples. As ... the whole bunchgood fruit stored in containers with decaying fruit ... survey of the New York market from 1972 to 1984, ...
... woods are the third most popular hardwood group in ... cherry. Used in production of beautiful hardwood flooring and ... strength. The pruned wood of pecan, a byproduct ... means of disposal. Increasingly though, pruned pecan is being ...
... 29, 2008) How do you grow future leaders to develop ... the wind. That,s what EPA,s Science to Achieve Results (STAR) ... at Berkeley with his three-year award. Matt collected ... and solar power facilities, and found that because solar and ...
Cached Biology News:Kazak apple research key to preventing blue mold 2Alternative to burning: environmentally sound disposal for wood chips 2Growing a garden of future environmental leaders 2
(Date:5/29/2015)... Research and Markets ( http://www.researchandmarkets.com/research/7bf7ff/cytogenetics ) ... report "Cytogenetics - Technologies, Markets and Companies" ... deals with cytogenetics in a broader sense rather ... chromosome structure and identify abnormalities related to disease. ... also referred to as molecular cytogenetics. The scope ...
(Date:5/29/2015)... Fort Worth, Texas (PRWEB) May 29, 2015 ... can grow. This is for a good reason--if used in ... work wonders for the offering of a business product or ... in which translation can have a positive effect on a ... product or service that anyone in the world can use, ...
(Date:5/28/2015)... May 28, 2015 ... has announced the addition of Jain ... Technologies, Markets and Companies"  to their ... report describes and evaluates animal biotechnology ... and pharmaceuticals as well as improvement ...
(Date:5/28/2015)... , May 27, 2015 Research ... of Jain PharmaBiotech,s new report "Neuroprotection - ... This report describes the role of ... injuries of the nervous system as well as ... many of the underlying mechanisms of damage to ...
Breaking Biology Technology:Global Cytogenetics Market Report 2015-2024 - Technologies, Markets and Companies 2Global Cytogenetics Market Report 2015-2024 - Technologies, Markets and Companies 3Three Ways Translation Can Help Businesses Grow 2Global Animal Biotechnology Report 2015 - Technologies, Markets and Companies Analysis to 2024 2Global Animal Biotechnology Report 2015 - Technologies, Markets and Companies Analysis to 2024 3Global Neuroprotection Market Report 2015-2024 - Drugs, Markets and Companies 2Global Neuroprotection Market Report 2015-2024 - Drugs, Markets and Companies 3
... Calif., Oct. 12 Raptor Pharmaceutical Corp. ("Raptor" or ... from the completed treatment phase of its open-label Phase ... in adolescent patients with non-alcoholic steatohepatitis ("NASH"), a progressive ... 5% of the U.S. population. At the completion of ...
... ... 2010 in Baltimore, MD, USA. This innovative annual event offers a prestigious roster ... development, crystallization, safety, scale-up, production, and emerging technologies. , ... Columbia, MD (PRWEB) October 11, 2009 -- METTLER ...
... to maintain skeletal strength and then breaking it down for ... osteoporosis break down too much bone without adequate bone replacement, ... new study at Duke suggest a targeted approach by which ... bone diseases. Diane Gesty-Palmer, M.D., a Duke Assistant Professor of ...
Cached Biology Technology:Raptor Pharmaceutical Reports Positive Interim Phase 2a Clinical Data in Non-Alcoholic Steatohepatitis (NASH) 2Raptor Pharmaceutical Reports Positive Interim Phase 2a Clinical Data in Non-Alcoholic Steatohepatitis (NASH) 3Raptor Pharmaceutical Reports Positive Interim Phase 2a Clinical Data in Non-Alcoholic Steatohepatitis (NASH) 4Raptor Pharmaceutical Reports Positive Interim Phase 2a Clinical Data in Non-Alcoholic Steatohepatitis (NASH) 5Raptor Pharmaceutical Reports Positive Interim Phase 2a Clinical Data in Non-Alcoholic Steatohepatitis (NASH) 617th International Process Development Conference to Feature Presentations on Safety, Process Development, Crystallization, PAT, Scale-Up and Production 2New approach for growing bone comes from Duke preclinical research 2
... Dr. P Set from different human ... More organs maybe available upon request. ... items from the whole set, and ... price. All Dr. P Set ...
... Steady gravity-fed delivery of buffer ... animal perfusion. Rat version. In Vivo ... results--Steady gravity-fed delivery of buffer and ... Easy to setup, use and clean--Complete ...
Mouse IL-31 RA Biotinylated Affinity Purified PAb...
... The steadylite plus assay system ... assay sensitivity, Designed for batch-processing ... for higher density microplates such ... Odor free, Convenient storage conditions ...
Biology Products: